3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
16
Neoplasms
4
Neoplasm Metastasis
4
Prostatic Neoplasms
3
Multiple Myeloma
3
Giant Cell Tumor of Bone
3
Carcinoma, Renal Cell
3
Smoldering Multiple Myeloma
2
Recurrence
2
Osteoporosis
2
Melanoma
2
Kidney Neoplasms
2
Bone Cysts, Aneurysmal
2
With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thyroid Cancer Metastatic
1
Parathyroid Neoplasms
1
Osteoporotic Fractures
1
Osteopetrosis, mild autosomal recessive form
1
Osteopetrosis, Autosomal Recessive 7
1
Osteoblastoma
1
Neoplastic Cells, Circulating
1
Musculoskeletal Pain
1
Mastocytosis, Systemic
1
Lung Neoplasms
1
Inflammatory Breast Neoplasms
1
Hyperparathyroidism, Primary
1
Granuloma, Giant Cell
1
Giant Cell Tumors
1
Interventions
midostaurin
2
obatoclax
1
ibrutinib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
denileukin diftitox
1
auricularum
1
Thalidomide
1
Ranitidine
1
Phlebotomy
1
Imatinib Mesylate
1
Ibuprofen
1
Everolimus
1
Diphenhydramine
1
Dexamethasone
1
Denosumab
1
Dasatinib
1
Cladribine
1
Calcium Dobesilate
1
Brentuximab Vedotin
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Mastocytosis, Systemic
×
Denosumab
×
Clear all
NCT03401060
2026-03-31
DenosuMast
Assistance Publique - Hôpitaux de Paris
Phase 3
Completed
24 enrolled